retatrutide weight loss retatrutide clinical trial VisualAbstract: reduces body by 17.5% in patients with obesity Retatrutide, Eli Lilly's next generation

Pregnant or nursing women: Insufficient safety data exists for this specific formulation during pregnancy

The indication for adult type 2 diabetes of this product has been approved for clinical use on August 29, 2023

A 5 mg vial dosage chart , a 5 mg/mL concentration chart , a 10 mg dosage chart , and a general compounded dose chart all provide the same fundamental information formatted for different starting points

Most insurance companies provide coverage for FDA-approved uses, reducing the out-of-pocket costs significantly, and patients using GLP-1 injections may pay as little as $25 with insurance

The name, address, and contact information of the compounding pharmacy

It can also lead to skin thickening and lumps of fat tissue developing under the skin, called lipohypertrophy